Navigation Links
Privacy Watchdog Condemns Google for Effort to Defund it: Calls for Greater Corporate Disclosure About Lobbying Efforts and Independent Privacy Chief
Date:2/23/2009

WASHINGTON, Feb. 23 /PRNewswire-USNewswire/ -- Consumer Watchdog President Jamie Court wrote Google's CEO Eric Schmidt today questioning the company's priorities following efforts by one of Google's top executives to dissuade a charitable foundation from supporting the nonpartisan group's privacy efforts.

"We have tried to constructively engage Google on its privacy problems for about six months now," Court wrote. "So it's remarkable that Google's most rapid and substantive response to our privacy concerns is a letter from your director of Corporate and Policy Communications to the charity funding our work seeking an end to its support.

"One would think Google's top executives have more important priorities than defunding a consumer group critical of your lack of privacy protections. Nonetheless I am writing to offer some observations about Google's less than open corporate culture, its opaque public policymaking division and some suggestions for change and moving forward."

Consumer Watchdog recommended that Google should openly disclose all its lobbying positions on Capitol Hill and create a Chief Privacy Ombudsman, independent of its corporate structure and general counsel, that reports directly to Schmidt and the board of directors.

Bob Boorstin, Google's Director of Corporate and Policy Communications, recently wrote to the Rose Foundation complaining of Consumer Watchdog's efforts: "Most recently, they accused our company -- without any evidence whatsoever and actually referencing 'a rumored lobbying effort' in a press release -- of trying to obtain permission to sell patient medical records. I am hoping that as you consider the activities of your grantees and whether to renew your commitments, you will take these kinds of activities into account and consider whether there might be better groups in which to place your trust and resources. I would like permission from you to address a
'/>"/>

SOURCE Consumer Watchdog
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Psychoanalysts Laud Members of Congress for Inclusion of Privacy Protections in Stimulus Bill
2. HIPAA privacy rule fails to adequately protect patient privacy and hampers health research
3. Consumer Watchdog Calls on Google to Cease Lobbying Effort to Allow Sale of Patient Medical Records; Urges Congress to Adopt Privacy Protections in Economic Stimulus Bill
4. HIPAA Privacy Rule Limits Americas Promise in Research
5. Economic Stimulus Package Could Impinge on Americans Health Privacy
6. Markel Corporation Announces New DataBreach(SM) Privacy Liability Coverage
7. Message Archiving Leader Privacy Networks Announces Free Anti-Spam Software to Businesses and Organizations
8. Importance of URACs HIPAA Privacy and Security Standards to Protect Personal Health Information Is Focus of New Issue Brief
9. URAC Rolls Out Revised Standards to Protect Personal Health Information and Boost Consumer Privacy on the Web
10. Workplace Privacy & Security as a Business Strategic Advantage
11. FairWarning(R) Announces New Privacy Surveillance Software Release

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...nhibOx, a leading developer of novel and effective...ned forces with MolPort, an innovator in rare chem...hemical trading platform and builds database of co...s database and its updates to computational chemis...irtual screening procedures. Once they identify su...
(Date:12/4/2009)...st-Selling author and Personal & Organizationa...Transformation through Accountability! , ...4, 2009 -- IMPAQ Accountability Business Consult...est-selling Author, renowned Speaker, and CEO &...ants Inc., will present at the 14th International ...
(Date:12/3/2009)...iropractic Traffic has gotten into the holiday spi...rketing tool. $1 gets chiropractors 3 months of un... Traffic is even including chiropractic promotiona... (PRWEB) December 3, 2009 -- Chiropractic Marke...tool. Chiropractic Marketing expertise provided b...
(Date:12/3/2009)...., Dec. 3 The development of Unive...MCPP) reached a milestone today with a "topping ou... construction at the new hospital that will replac..., (Photo: http://www.newscom.com/cgi-bin/prnh/... a steelworkers, tradition in which a steel beam c...
(Date:12/3/2009)... The American Medical A...tates District Court for the Southern District of ...reviously disclosed $350 million settlement that w...Health Group. ,, The action brought by the AMA,...ouri State Medical Association, along with several...
Breaking Medicine News(10 mins):Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference 2Health News:New Chiropractic Marketing: A $1 Chiropractic Marketing Tool that Can Make Users $1000s 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2
... 26 days across deserts and mountains, a group of ...oss-country motorbike// expedition to spread aware...ebruary 26 from Bangalore, Karnataka, the group of...in other such expeditions before but they have bee...
...ildhood could fall victims to other types of cance... Early attention and prompt treatment could help...es more likely to develop other types of cancers t...ute lymphoblastic leukemia as children and adolesc...
...ng center and cervical cancer screening program wi...rba Gandhi Hospital// (KGH) at Chennai, capital of... to determine the cause of abnormalities found in ...ican anatomist. It is used to detect changes that ...
...ave demanded a commitment for more funding if talk...nt review of the NHS Wheelchair// and Seating Serv...0m a year. But the Scottish Executive has agreed a... too lightly. Meanwhile BBC Scotland has come to u...
... been established at Kattankulathur, off Chennai, ...//. It will be functioning as part of the SRM Med.... Sathyanarayanan, Vice Chancellor, SRM University... It would commence from the academic year 20...
...tte smoking may actually aid in decreasing the ris...quential association// between smoking and reduced...s conducted by Evan L. Thacker and colleagues from...ibilities of neuro-protective chemicals that may b...
Other Medicine News:Health News:Cross-country Mobike Expedition to Spread AIDS Awareness 2Health News:New School of Public Health in Chennai 2
(Date:12/3/2009)..., , PISCATAWAY, N.J., Dec. 3 /PRNewswir...letin Board: MLSS), the recognized leader in advan...t had entered into a joint venture with China Nati...) and Yichang Humanwell Pharmaceutical Co. Ltd., b... (the "PRC"), to develop orthopedic and epidural d...
(Date:12/3/2009)..., , WALTHAM, Mass., Dec. 3 /PRNewswire...ing research and advisory firms focusing on pharma... type 2 diabetes drug market in Brazil will grow f...The projected 15 percent annual growth rate is att...pulation, increased use of new generation antidiab...
(Date:12/3/2009)..., , SAN DIEGO, Dec. 3 Amir...sitive data from a Phase 1 clinical study of AM461...f the DP2 (also known as CRTH2) receptor. ,, ...tional pharmacodynamic (PD) effect can be achieved...date demonstrates a good safety profile. AM461 is...
Breaking Medicine Technology:Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program 47480 1BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program 47480 2BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program 47480 3Record 73 4 Million Pounds Collected in Letter Carriers National Food Drive 47476 1Record 73 4 Million Pounds Collected in Letter Carriers National Food Drive 47476 2Kendle Expands Asia Pacific Operations with Opening of Offices in Kuala Lumpur Bangkok and Manila 12390 1Kendle Expands Asia Pacific Operations with Opening of Offices in Kuala Lumpur Bangkok and Manila 12390 2Kendle Expands Asia Pacific Operations with Opening of Offices in Kuala Lumpur Bangkok and Manila 12390 3
...at Tufts Medical Center have created a formula for... certain genetic profiles and lifestyle behaviors ...tion (AMD), a potentially blinding condition that ...mericans and is increasing dramatically as the pop...eddon, MD, ScM, Professor of Ophthalmology at Tuf...
...44th Annual Meeting of EASL , , Management to Dis...nancial Results Call at 5 P.M. EDT Today , , SAN...sdaq: ANDS ) today announced that ANA598, the Co...inhibitor, demonstrated potent antiviral activity ...se Ib study in which patients chronically infected...
Other Medicine Technology:Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD) 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8
... A Test gives your laboratory clear-cut results in...icile, you can't afford to wait. For any laborator...t its suspected C. difficile samples for testing, ...ill cut costs and minimize your time-to-results wh...
Clearview C DIFF A
...ion, accuracy and easy operation TOMEYs patented l...viding high resolution. The laser alignment system... cone design eliminates nose & brow shadow & provi...l of the rings promotes patient comfort. New TMS S...
Pachycam
Medicine Products: